TLT.V
Price:
$0.185
Market Cap:
$45.84M
Theralase Technologies Inc., a clinical stage pharmaceutical company, engages in the research and development of photo dynamic compounds (PDCs) and their associated drug formulations to treat cancer, bacteria, and viruses in Canada, the United States, and internationally. It also designs, develops, manufactures, and markets patented and proprietary super-pulsed laser technology for the healing of chronic knee pain, as well as for off-label use to heal various nerve, muscle, and joint conditions. In addition, the company develops TLD-1433, which is in Phase II for the treatment of Bacillus Calmette Guérin - Unresponsive Carcinoma In-Situ non-muscle invasive bladder cancer. Further, its produc...[Read more]
Industry
Medical - Devices
IPO Date
2008-02-13
Stock Exchange
TSXV
Ticker
TLT.V
According to Theralase Technologies Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -9.25. This represents a change of -20.43% compared to the average of -11.62 of the last 4 quarters.
The mean historical PE Ratio of Theralase Technologies Inc. over the last ten years is -9.86. The current -9.25 PE Ratio has changed 9.28% with respect to the historical average. Over the past ten years (40 quarters), TLT.V's PE Ratio was at its highest in in the September 2015 quarter at -3.52. The PE Ratio was at its lowest in in the December 2022 quarter at -19.55.
Average
-9.86
Median
-8.29
Minimum
-17.58
Maximum
-5.09
Discovering the peaks and valleys of Theralase Technologies Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 153.97%
Maximum Annual PE Ratio = -5.09
Minimum Annual Increase = -52.03%
Minimum Annual PE Ratio = -17.58
Year | PE Ratio | Change |
---|---|---|
2024 | -14.95 | 72.56% |
2023 | -8.66 | -31.67% |
2022 | -12.68 | -27.87% |
2021 | -17.58 | 153.97% |
2020 | -6.92 | 4.48% |
2019 | -6.62 | -46.75% |
2018 | -12.44 | 144.33% |
2017 | -5.09 | -11.62% |
2016 | -5.76 | -27.29% |
2015 | -7.92 | -52.03% |
The current PE Ratio of Theralase Technologies Inc. (TLT.V) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-12.10
5-year avg
-12.16
10-year avg
-9.86
Theralase Technologies Inc.’s PE Ratio is less than VentriPoint Diagnostics Ltd. (-3.63), greater than Theralase Technologies Inc. (-10.77), less than Reliq Health Technologies Inc. (0), less than Microbix Biosystems Inc. (0), less than null (25.27),
Company | PE Ratio | Market cap |
---|---|---|
-3.63 | $19.16M | |
-10.77 | $34.69M | |
0 | $46.65M | |
0 | $50.69M | |
25.27 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Theralase Technologies Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Theralase Technologies Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Theralase Technologies Inc.'s PE Ratio?
How is the PE Ratio calculated for Theralase Technologies Inc. (TLT.V)?
What is the highest PE Ratio for Theralase Technologies Inc. (TLT.V)?
What is the 3-year average PE Ratio for Theralase Technologies Inc. (TLT.V)?
What is the 5-year average PE Ratio for Theralase Technologies Inc. (TLT.V)?
How does the current PE Ratio for Theralase Technologies Inc. (TLT.V) compare to its historical average?